Differentiating Unipolar and Bipolar Depression in Young Adults Using fMRI
Bipolar Disorder · Major Depression
Bottom Line
View on ClinicalTrials.gov: NCT01811147 ↗Study Design & Population
- Study type
- Interventional
- Phase
- Phase 4
- Interventions
- Selective Serotonin Reuptake Inhibitor (SSRI) (Drug)
- Age
- Pediatric, Adult · 15+ yrs
- Sex
- All
- Sponsor
- The Cleveland Clinic
- Primary completion
- Jun 2018
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY HAM-D 17 Item: Hamilton Depression Rating Scale |
6.6; 4.91; 2.333; 3.75 | — |
| SECONDARY YMRS: Young Mania Rating Scale |
0.2; 0; 0; 1.75 | — |
Summary
Eligibility Criteria
INCLUSION CRITERIA FOR BIPOLAR DEPRESSED PATIENTS:
- Ages 15 - 30 years (inclusive) and able to give voluntary informed consent (parents must also sign consent for subjects under 18)
- Satisfy criteria for Diagnostic and Statistical Manual 4th edition (DSM-IV-TR) for Bipolar I or II disorder
- Satisfy criteria for DSM-IV depressive episode-current
- 17-item Hamilton Depression Rating Scale > 15 but 15 and < 25.
- Young Mania Rating Scale (YMRS) score < 10
- Satisfy safety criteria to undergo an MRI scan
- Able to be managed as outpatients during the study as ascertained by the following - i. Clinical Global Severity Scale < 5 i.e. moderately ill; ii. No significant suicidal or homicidal ideation or grossly disabled
ADDITIONAL INCLUSION CRITERIA FOR HIGH RISK UD (HRUD) PATIENTS BESIDE THE INCLUSION CRITERIA FOR UD:
At least one of the following:
- Family history of bipolar disorder in at least one first degree relative
- History of any sub-threshold hypomania symptoms
- History of mood episode related psychotic symptoms
ADDITIONAL INCLUSION CRITERIA FOR LOW RISK UD (HRUD) PATIENTS BESIDE THE INCLUSION CRITERIA FOR UD:
- No family history of BD in a first or a second degree relative
- No past history of any sub-threshold hypomania symptoms
- No history of psychotic symptoms
EXCLUSION CRITERIA FOR DEPRESSION AND BIPOLAR SUBJECTS:
- Meeting DSM-IV criteria for schizophrenia, schizophreniform disorder, schizoaffective disorder, mental retardation, pervasive developmental disorder.
- History of receiving electroconvulsive therapy in the past 1 year
- Use of neuroleptics, mood stabilizers or benzodiazepines in the past 2 weeks.
- Use of antidepressants in the past 2 weeks.
- If on fluoxetine in the past, then should not have been on this medication for 5 weeks.
- Acutely suicidal or homicidal or requiring inpatient treatment.
- Meeting DSM-IV criteria for other substance/alcohol dependence within the past 6 months or abuse in the past 3 months, excluding caffeine or nicotine. The criteria will be evaluated by interview and urinary toxicology screening. The use of caffeine or nicotine will be recorded.
- Use of alcohol in the past 1 week before the MRI scan.
- No serious acute or chronic medical or neurological illness, including previously known HIV positive status (due to possible CNS involvement) as assessed by history, physical examination and laboratory examination including EKG, CBC and blood chemistry.
- Current pregnancy or breast feeding.
- Metallic implants or other contraindication to MRI.
INCLUSION CRITERIA FOR HEALTHY CONTROLS: Healthy subjects matched for age, gender and ethnicity will be included
- Ages 15 - 30 years (inclusive) and able to give voluntary informed consent (Parental consent must also be obtained for those under 18 years old)
- No current or past history of psychiatric illness or substance abuse or dependence.
- No current or past history of psychiatric illness or substance abuse or dependence in a first degree relative.
EXCLUSION CRITERIA FOR HEALTHY CONTROLS:
- Pregnant or breast feeding.
- Metallic implants or other contraindication to MRI.
- Significant family history of psychiatric or neurological illness.
- Currently taking any prescription or centrally acting medications.
- Serious acute or chronic medical or neurological illness as assessed by history, physical examination and laboratory examination including CBC and blood chemistry.
- Use of alcohol in the past 1 week and not being able to avoid alcohol use during the course of the study.
Data sourced from ClinicalTrials.gov (NCT01811147). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.